82 related articles for article (PubMed ID: 2717641)
1. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells.
Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA
Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641
[No Abstract] [Full Text] [Related]
2. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
3. [Anti-tumor activity and immune responses induced by human cancer-associated mucin core peptide].
Ma Y; Yuan M; Fei L
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):419-21. PubMed ID: 9387291
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
Finn OJ
Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
[No Abstract] [Full Text] [Related]
5. Identification of a human pancreatic duct tissue-specific antigen.
Gold DV; Hollingsworth P; Kremer T; Nelson D
Cancer Res; 1983 Jan; 43(1):235-8. PubMed ID: 6336602
[TBL] [Abstract][Full Text] [Related]
6. Morphologic, biologic and biochemical characteristics of three human pancreatic ductal adenocarcinomas established as xenotransplants in the nude mouse.
Kyriazis AP; Kyriazis AA
In Vivo; 1990; 4(2):137-43. PubMed ID: 1966587
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
Brown JP; Linsley PS; Horn D
Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
[No Abstract] [Full Text] [Related]
8. Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen.
Lan MS; Khorrami A; Kaufman B; Metzgar RS
J Biol Chem; 1987 Sep; 262(26):12863-70. PubMed ID: 2442170
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
Jerome KR; Domenech N; Finn OJ
J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
[TBL] [Abstract][Full Text] [Related]
10. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosis.
Uozumi N; Gao C; Yoshioka T; Nakano M; Moriwaki K; Nakagawa T; Masuda T; Tanabe M; Miyoshi E
J Proteome Res; 2010 Dec; 9(12):6345-53. PubMed ID: 20954701
[TBL] [Abstract][Full Text] [Related]
12. Biologic instability of pancreatic cancer xenografts in the nude mouse.
Schmied BM; Ulrich AB; Matsuzaki H; El-Metwally TH; Ding X; Fernandes ME; Adrian TE; Chaney WG; Batra SK; Pour PM
Carcinogenesis; 2000 Jun; 21(6):1121-7. PubMed ID: 10836999
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.
Kong D; Nishino N; Shibusawa M; Kusano M
Tissue Cell; 2007 Aug; 39(4):217-23. PubMed ID: 17560620
[TBL] [Abstract][Full Text] [Related]
14. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated antigen in human pancreatic cancer.
Schultz DR; Yunis AA
J Natl Cancer Inst; 1979 Apr; 62(4):777-85. PubMed ID: 85737
[No Abstract] [Full Text] [Related]
16. Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse.
Kyriazis AP; McCombs WB; Sandberg AA; Kyriazis AA; Sloane NH; Lepera R
Cancer Res; 1983 Sep; 43(9):4393-401. PubMed ID: 6871872
[TBL] [Abstract][Full Text] [Related]
17. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958
[TBL] [Abstract][Full Text] [Related]
18. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9.
Iwamura T; Katsuki T; Ide K
Jpn J Cancer Res; 1987 Jan; 78(1):54-62. PubMed ID: 3102439
[TBL] [Abstract][Full Text] [Related]
20. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies.
Hixson DC; Brown J; McBride AC; Affigne S
Exp Mol Pathol; 2000 Jun; 68(3):152-69. PubMed ID: 10816384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
